Company Overview
- Headquarters
- 400 Fifth Avenue 210, Waltham MA
- Website
- ardelyx.com
- in****@ardelyx.com
- Phone
- (510) 745-****
- Employees
- 378
- Founded in
- 2007
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:ARD
- NAICS Code
- 3254, 541714, 32, 5417, 54, 325, 54171, 541
- SIC Code
- 28, 283, 87, 873
Financials & Stats
Revenue
$5B
Who is Ardelyx Inc
Ardelyx Inc. is a biotechnology company headquartered in Waltham, Massachusetts. With a workforce of 378 employees, the company focuses on the research, development, and commercialization of groundbreaking medications. Ardelyx specializes in developing innovative treatments for unmet medical needs. Their portfolio includes two commercially available products approved in the United States: IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). These medications target various conditions, with tenapanor demonstrating effectiveness in managing both hyperphosphatemia and irritable bowel syndrome. Ardelyx has established strategic partnerships for the global development and commercialization of tenapanor. Kyowa Kirin markets PHOZEVEL® (tenapanor) in Japan for hyperphosphatemia treatment, while Knight Therapeutics handles IBSRELA sales in Canada. Additionally, a New Drug Application for tenapanor to address hyperphosphatemia has been submitted in China, in collaboration with Fosun Pharma. For inquiries or further information, please visit Ardelyx's website at ardelyx.com.
Company Leadership
Ardelyx Inc Industry Tags
Ardelyx Inc Tech Stack
Companies Similar to Ardelyx Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Ardelyx Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
5M | 23 | Princeton, NJ | 1987 | |
5M | 21 | Waltham, MA | 1998 | |
5M | Las Vegas, NV | |||
5M | Baton Rouge, LA | |||
5M | 5 | Pittsburgh, PA | 2004 |